文献速递神经肿瘤

手术量与大部脑肿瘤切除术患者的死亡率、主要并发症及再入院呈线性相关

Procedural volume is linearly associated with mortality, major complications, and readmissions in patients undergoing malignant brain tumor resection.
PubMed 文献 · J Neurooncol · 2024-09-12

基于美国全国再入院数据库2016至2018年34,486例恶性脑肿瘤切除术患者,采用多变量分析及样条模型评估医院年手术量与结局的连续关联。结果显示手术量与死亡率、主要并发症、30天及90天再入院在特定截点前呈线性负相关,该线性关系可用于估算任意两个手术量之间不良结局的相对可能性。

要点

  • 年手术量1-65例范围内,每增加1例,死亡率风险比OR为0.988(95%CI 0.982-0.993,P<0.0001)。
  • 年手术量1-41例范围内,主要并发症风险比OR为0.983(95%CI 0.979-0.988,P<0.0001)。
  • 年手术量1-24例范围内,30天再入院风险比OR为0.987(95%CI 0.979-0.995,P=0.001)。

核心结论

  • 多变量分析显示,医院年手术量在特定截点前与死亡率、主要并发症及30/90天再入院呈线性相关。
  • 所得的线性关系可用于计算任意两个手术量之间不良结局的相对可能性。

研究设计与样本

  • 回顾性队列研究,使用全国再入院数据库(NRD)以ICD-10编码识别2016至2018年34,486例恶性脑肿瘤切除术患者。
  • 采用多变量分析评估手术量与死亡率、主要并发症及30/90天再入院的关联。
  • 手术量作为连续变量,采用两段/三段样条模型,基于准信息准则(QIC)选择最佳模型性能的节点位置。

主要发现

  • 年手术量1-65例范围内,每增加1例手术,死亡风险比OR为0.988(95%CI 0.982-0.993,P<0.0001)。
  • 年手术量1-41例范围内,主要并发症风险比OR为0.983(95%CI 0.979-0.988,P<0.0001)。
  • 年手术量1-24例范围内,30天再入院风险比OR为0.987(95%CI 0.979-0.995,P=0.001)。
  • 年手术量1-23例范围内,90天再入院风险比OR为0.989(95%CI 0.983-0.995,P=0.0003)。
  • 年手术量24-349例范围内,90天再入院风险比OR为0.9994(95%CI 0.999-1,P=0.01)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Improved outcomes have been noted in patients undergoing malignant brain tumor resection at high-volume centers. Studies have arbitrarily chosen high-volume dichotomous cutoffs and have not evaluated volume-outcome associations at specific institutional procedural volumes. We sought to establish the continuous association of volume with patient outcomes and identify cutoffs significantly associated with mortality, major complications, and readmissions. We hypothesized that a linear volume-outcome relationship can estimate likelihood of adverse outcomes when comparing any two volumes. METHODS: The patient cohort was identified with ICD-10 coding in the Nationwide Readmissions Database(NRD). The association of volume and mortality, major complications, and 30-/90-day readmissions were evaluated in multivariate analyses. Volume was used as a continuous variable with two/three-piece splines, with various knot positions to reflect the best model performance, based on the Quasi Information Criterion(QIC). RESULTS: From 2016 to 2018, 34,486 patients with malignant brain tumors underwent resection. When volume was analyzed as a continuous variable, mortality risk decreased at a steady rate of OR 0.988 per each additional procedure increase for hospitals with 1-65 cases/year(95% CI 0.982-0.993, p < 0.0001). Risk of major complications decreased from 1 to 41 cases/year(OR 0.983, 95% CI 0.979-0.988, p < 0.0001), 30-day readmissions from 1 to 24 cases/year(OR 0.987, 95% CI 0.979-0.995, p = 0.001) and 90-day readmissions from 1 to 23 cases/year(OR 0.989, 95% CI 0.983-0.995, p = 0.0003) and 24-349 cases/year(OR 0.9994, 95% CI 0.999-1, p = 0.01). CONCLUSION: In multivariate analyses, institutional procedural volume remains linearly associated with mortality, major complications, and 30-/90-day readmission up to specific cutoffs. The resulting linear association can be used to calculate relative likelihood of adverse outcomes between any two volumes.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Han JS, Wenger T, Demetriou AN, et al. Procedural volume is linearly associated with mortality, major complications, and readmissions in patients undergoing malignant brain tumor resection. J Neurooncol. 2024. PMID: 39266885. doi:10.1007/s11060-024-04800-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。